Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, FY2025
10,022
Period ended Dec 31, 2025
Change on a year earlier
+503.0%
1,662 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating income (loss) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,022 | +503.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 1,662 | -78.1% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 7,605 | +3.8% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 7,330 | -26.1% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 9,918 | +143.6% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 4,071 | -5.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 4,287 | -47.7% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 8,200 | -41.9% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 14,124 | -19.9% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 17,633 | -20.5% | Form 10-K (filed 2017-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 22,193 | +45.4% | Form 10-K (filed 2016-02-24) ↗ |
| FY2014 | Dec 31, 2014 | 15,265 | +237.4% | Form 10-K (filed 2015-02-25) ↗ |
| FY2013 | Dec 31, 2013 | 4,524 | +12.8% | Form 10-K (filed 2015-02-25) ↗ |
| FY2012 | Dec 31, 2012 | 4,010 | +5.8% | Form 10-K (filed 2015-02-25) ↗ |
| FY2011 | Dec 31, 2011 | 3,790 | -4.4% | Form 10-K (filed 2012-02-23) ↗ |
| FY2010 | Dec 31, 2010 | 3,962 | +12.3% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 3,529 | +31.8% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 2,679 | +23.7% | Form 10-K (filed 2010-03-01) ↗ |
| FY2007 | Dec 31, 2007 | 2,165 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Operating income (loss) ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_opinc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.